Becton Dickinson BDX
NYSE BDX
$192.00 +4.38 (+2.33%)
At close: Aug 21, 2026 · 4:00 PM EDT

Becton Dickinson (BDX) Liabilities and Shareholders Equity (2009 - 2026)

Becton Dickinson (BDX) posted quarterly Liabilities and Shareholders Equity of $50.8 billion for Q1 2026, down 6.67% year-over-year from $54.5 billion in Q1 2025, and down 7.31% quarter-over-quarter from $54.8 billion in Q4 2025.

Becton Dickinson (BDX) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Becton Dickinson (BDX) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $50.8 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 6.67% year-over-year to $50.8 billion; the TTM figure through Mar 2026 stood at $215.9 billion (down 2.75% YoY), while the FY2025 annual figure was $55.3 billion, down 3.42% from the prior year.
  • Liabilities and Shareholders Equity fell to $50.8 billion in Q1 2026 per BDX's latest filing, from $54.8 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $57.3 billion in Q3 2024 and bottomed at $50.8 billion in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $54.0 billion across 5 years, with a median of $54.4 billion in 2023.
  • Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity grew 8.54% — and 2026, when it declined 6.67%.
  • Becton Dickinson's Liabilities and Shareholders Equity stood at $53.1 billion in 2022, then fell by 1.61% to $52.3 billion in 2023, then climbed by 4.57% to $54.7 billion in 2024, then rose by 0.32% to $54.8 billion in 2025, then decreased by 7.31% to $50.8 billion in 2026.
  • Business Quant data shows BDX's Liabilities and Shareholders Equity at $50.8 billion in Q1 2026, $54.8 billion in Q4 2025, and $55.3 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 20.88 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 50.73 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 31.10 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 8.97 Bn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 39.35 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 4.08 Bn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 14.24 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 12.48 Bn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 19.79 Bn
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn 6.42 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 50.73 Bn
Mar 31, 2026 50.83 Bn
Dec 31, 2025 54.84 Bn
Sep 30, 2025 55.33 Bn
Jun 30, 2025 54.90 Bn
Mar 31, 2025 54.47 Bn
Dec 31, 2024 54.67 Bn
Sep 30, 2024 57.29 Bn
Jun 30, 2024 55.58 Bn
Mar 31, 2024 54.16 Bn
Dec 31, 2023 52.27 Bn
Sep 30, 2023 52.78 Bn
Jun 30, 2023 53.02 Bn
Mar 31, 2023 54.39 Bn
Dec 31, 2022 53.13 Bn
Sep 30, 2022 52.93 Bn
Jun 30, 2022 53.20 Bn
Mar 31, 2022 54.79 Bn
Dec 31, 2021 53.36 Bn
Sep 30, 2021 53.87 Bn